IHS Chemical Week

World News and Views :: Top of the News

Merck Serono appoints head of R&D

1:10 AM MDT | July 15, 2014 | Natasha Alperowicz

Merck Serono, the biopharmaceutical division of Merck KGaA, has announced the appointment of Luciano Rossetti as executive v.p. and head/R&D as of 21 July.  In his most recent role, Rossetti acted as senior v.p./late-stage development at Merck Sharp & Dohme (MSD).  He was responsible for the clinical development from phase two to phase five across all therapeutic areas. At MSD, he played a key role in shaping and implementing the development strategy of several potential breakthrough compounds, such as anti PD-1. He also restructured the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa